Compare NetFlix Inc (NFLX) vs Vertex Pharmaceuticals Incorporated (VRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NetFlix Inc vs Vertex Pharmaceuticals Incorporated — how do they compare? NetFlix Inc trades at $74.78 (market cap $311.42B), while Vertex Pharmaceuticals Incorporated trades at $528 (market cap $134.25B). The key difference: NetFlix Inc is far larger — about 2.3× Vertex Pharmaceuticals Incorporated's market cap, and Vertex Pharmaceuticals Incorporated is trading nearer its 52-week high, NetFlix Inc nearer its low. Which is the better fit depends on your goals.
| NFLX | VRTX | |
|---|---|---|
Market Cap | $311.42B | $134.25B |
Sector | Consumer Cyclical | Health |
52-Week High | $126.33 | $529.65 |
52-Week Low | $67.60 | $376.62 |
Enterprise Value | $316.60B | $128.37B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Netflix (NFLX) trades at $74.79, up 0.88% on the day, showing resilience amid recent volatility. The stock exhibits strong fundamentals with robust revenue growth, expanding net income margins, and consistent earnings beats. Technical analysis indicates a bullish trend with key support at $74 and resistance at $77. Recent news highlights focus on the company's advertising business expansion and content performance.
The outlook for NFLX remains positive driven by advertising revenue growth and global subscriber expansion. Key risks include intense streaming competition and market sentiment shifts. Analyst consensus is strongly bullish with a $90.45 price target, suggesting significant upside potential from current levels.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NetFlix Inc
Netflix Inc. is an Internet subscription service for watching television shows and movies. Subscribers can instantly watch unlimited television shows and movies streamed over the Internet to their televisions, computers, and mobile devices and in the United States, subscribers can receive standard definition DVDs and Blu-ray Discs delivered to their homes.
Read more on NFLX →About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →
